76th Annual Congress of Neurological Surgeons
October 31 – November 4, 2026
Booth 767
Washington, D.C., USA
The Congress of Neurological Surgeons Annual Meeting brings neurosurgeons, researchers and related healthcare professionals from around the world together to explore the latest neurosurgical innovations and advancements. We are excited to connect with attendees interested in learning more about how robotic-assisted microsurgery with the Symani® Surgical System is expanding possibilities for precision in complex procedures.
Related News
MMI Raises $125M in Series D to Accelerate Commercial Growth of the Symani Surgical System Worldwide
MMI Raises $125M in Series D to Accelerate Commercial Growth of the Symani Surgical System Worldwide
MMI Receives FDA Approval to Advance to Phase II of Patient Enrollment in Groundbreaking REMIND Microsurgical Study in Alzheimer’s Patients
MMI Receives FDA Approval to Advance to Phase II of Patient Enrollment in Groundbreaking REMIND Microsurgical Study in Alzheimer’s Patients
MMI Earns Gold Edison Award for Symani, Recognized for Expanding Access to Life-Changing Surgical Treatment Options
MMI Earns Gold Edison Award for Symani, Recognized for Expanding Access to Life-Changing Surgical Treatment Options
“First U.S. Patients Treated With Microrobotic Surgery For Alzheimer’s”
“First U.S. Patients Treated With Microrobotic Surgery For Alzheimer’s”
MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study
MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study
MMI Introduces World’s First Microsurgical Suture for Robotics
MMI Introduces World’s First Microsurgical Suture for Robotics
“This Startup Wants To Use Mini Robots To Treat Alzheimer’s”
“This Startup Wants To Use Mini Robots To Treat Alzheimer’s”
New surgical treatment option using robotic microsurgery brings relief to breast cancer survivor with lymphedema
New surgical treatment option using robotic microsurgery brings relief to breast cancer survivor with lymphedema
MMI to Present on Company Momentum and Innovation at 44th Annual J.P. Morgan Healthcare Conference
MMI to Present on Company Momentum and Innovation at 44th Annual J.P. Morgan Healthcare Conference
MMI Wins FDA Clearance and Completes First U.S. Clinical Use of Robotic Microsurgical Dissection Instruments with Symani
MMI Wins FDA Clearance and Completes First U.S. Clinical Use of Robotic Microsurgical Dissection Instruments with Symani
MMI Announces CPT Code and CMS Reimbursement for Robotic Lymphatic Surgery, Unlocking Market Access and Growth Potential
MMI Announces CPT Code and CMS Reimbursement for Robotic Lymphatic Surgery, Unlocking Market Access and Growth Potential
Leading New Jersey hospital treats first patient with new robotic surgical approach to manage symptoms of breast-cancer related lymphedema
